Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 20, 2003

View Archived Issues

Two series of GSK-3 kinase inhibitors discovered by Lilly researchers

Takeda claims JNK inhibitors for heart failure, arthritis and other uses

Ferring presents new plasma kallikrein inhibitors for use in inflammatory disorders

Novel 5-HT receptor ligands reported in recent patent

Optically active IKK-beta inhibitor covered by Bayer patent

Novel antimalarial artemisin derivatives reported in Bayer patent

Tigecycline as an alternative to vancomycin in MRSA osteomyelitis

Chemokine inhibition as potential novel therapy for endometriosis, postsurgical adhesions

ACP-2127 advanced into preclinical testing

Archemix selects ARC-183 for development

AstraZeneca and Abgenix enter cancer antibody alliance

FDA accepts for filing NDA for ultra-low-dose transdermal estrogen patch

Cardiome and Fujisawa enter RSD-1235 partnership

IDM to coordinate Europe project for optimization of prostate cancer vaccine

Medicure seeks clearance to begin phase II study of MC-1 in CABG patients

Oxytrex phase II study meets endpoints

Visudyne approved in Japan for wet AMD

Titan acquires congestive heart failure drug DITPA

SBIR grant funds development of niprisan for sickle cell disease

Community-based trial compares Concerta and Strattera for ADHD

Liraglutide has beneficial effects on food intake and body weight in obese minipigs

Vasopressin V2 receptor antagonist effective in early and established polycystic kidney disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...